<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 21.1: Strategic Synthesis of the C.A.L.M. Framework</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE theme for Treatment Planning */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #eff6ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #3b82f6;
            margin: 35px 0 15px 0;
            font-weight: 600;
        }

        /* Paragraphs & Text */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #3b82f6, #1e3a8a);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
            flex-shrink: 0;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            color: white;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(180px, 1fr));
            gap: 25px;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 36px;
            font-weight: 700;
            margin-bottom: 5px;
        }

        .stat-label {
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 1px;
            opacity: 0.9;
        }

        /* Data Table */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background: #f3f4f6;
            padding: 15px;
            font-weight: 600;
            color: #1e3a8a;
            border-bottom: 2px solid #e5e7eb;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #f3f4f6;
            vertical-align: top;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Principle Cards */
        .principle-card {
            background: white;
            border-left: 5px solid #3b82f6;
            padding: 24px 28px;
            margin-bottom: 18px;
            border-radius: 0 14px 14px 0;
            box-shadow: 0 2px 10px rgba(0, 0, 0, 0.04);
        }

        .principle-title {
            font-weight: 700;
            color: #1e3a8a;
            margin-bottom: 8px;
        }

        /* Check Understanding */
        .check-understanding {
            background: #fdfbf7;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0f9ff;
            border-radius: 8px;
            color: #1e40af;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f3f4f6;
            padding: 25px;
            border-radius: 12px;
            margin-top: 40px;
        }

        .references-box {
            margin-top: 40px;
            padding: 25px;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
            margin-top: 40px;
        }

        .footer-logo {
            max-width: 120px;
            opacity: 0.8;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 21: L2: Treatment Planning</p>
            <h1 class="lesson-title">Lesson 1: Strategic Synthesis of the C.A.L.M. Framework</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Expert Level Certification</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#timeline"><span class="section-num">1</span>The Clinical Timeline</a></li>
                <li><a href="#readiness"><span class="section-num">2</span>Assessing Readiness</a></li>
                <li><a href="#smart"><span class="section-num">3</span>Setting SMART Goals</a></li>
                <li><a href="#hierarchy"><span class="section-num">4</span>The Hierarchy of Intervention</a></li>
                <li><a href="#asbs"><span class="section-num">5</span>The ASBS Metric</a></li>
                <li><a href="#pacing"><span class="section-num">6</span>Metabolic Pacing</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Synthesize the four pillars of C.A.L.M. into a cohesive 12-month clinical roadmap.</li>
                <li>Determine client "metabolic reserve" to prevent intervention-induced flares.</li>
                <li>Differentiate between biomarker targets and subjective symptom relief in goal setting.</li>
                <li>Establish a hierarchy of intervention: prioritizing Containment (C) over Addressing (A).</li>
                <li>Utilize the Autoimmune Symptom Burden Scale (ASBS) for quantitative progress tracking.</li>
            </ul>
        </div>

        <p>Welcome to the synthesis phase of your journey as an Autoimmune Specialist. To this point, you have mastered the individual mechanics of inflammation, root causes, lifestyle medicine, and remission maintenance. However, the mark of a true <span class="highlight">Master Practitioner</span> is not just knowing <em>what</em> to do, but <em>when</em> and <em>in what order</em> to do it.</p>

        <p>Treatment planning in autoimmunity is not a linear checklist; it is a dynamic orchestration. If we address root causes (A) like stealth infections or heavy metals before we have adequately contained systemic inflammation (C), we risk a "healing crisis" that can shatter client compliance and trigger a severe flare. This lesson provides the strategic blueprint for integrating the <span class="highlight">C.A.L.M. Autoimmune Protocolâ„¢</span> into a high-level clinical timeline.</p>

        <h2 id="timeline">1. Integrating the C.A.L.M. Clinical Timeline</h2>
        <p>A standard autoimmune recovery timeline typically spans 6 to 18 months, depending on the severity of tissue damage and the duration of the disease. We categorize this into three distinct phases of synthesis:</p>

        <div class="principle-card">
            <p class="principle-title">Phase I: The Stabilizing Window (Days 1-90)</p>
            <p class="principle-text">Focus is predominantly on <strong>Containment (C)</strong> and <strong>Lifestyle (L)</strong>. The goal is to lower the "cytokine storm" and establish a baseline of safety. We remove dietary triggers and optimize sleep/circadian rhythms to expand the client's metabolic reserve.</p>
        </div>

        <div class="principle-card">
            <p class="principle-title">Phase II: The Investigative Window (Months 4-9)</p>
            <p class="principle-text">Once inflammation is dampened, we shift focus to <strong>Addressing Root Causes (A)</strong>. This is where we introduce gut repair protocols, antimicrobial interventions, or detoxification support. Because the client is more stable, they can better tolerate the physiological stress of these interventions.</p>
        </div>

        <div class="principle-card">
            <p class="principle-title">Phase III: The Resiliency Window (Months 10+)</p>
            <p class="principle-text">Focus shifts to <strong>Maintenance (M)</strong>. We begin strategic reintroductions, expand the diet, and focus on nervous system regulation to ensure long-term remission and prevent future flares.</p>
        </div>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">64%</div>
                    <div class="stat-label">Higher success rate with phased intervention</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">12-18</div>
                    <div class="stat-label">Months for full tissue remodeling</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">3.2x</div>
                    <div class="stat-label">Retention increase using ASBS metrics</div>
                </div>
            </div>
        </div>

        <h2 id="readiness">2. Determining "Readiness for Change" & Metabolic Reserve</h2>
        <p>One of the most common mistakes in functional medicine is "over-prescribing" to a depleted client. Before initiating a rigorous protocol, the practitioner must assess the client's <span class="highlight">Metabolic Reserve</span>â€”the capacity of the body to respond to physiological stress.</p>

        <p>Interventions like the AIP elimination diet or a SIBO protocol require significant executive function and cellular energy. If a client is in a state of total adrenal exhaustion (HPA axis dysregulation) or severe mitochondrial dysfunction, even "good" interventions can be perceived by the immune system as a threat.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ“‹</div>
                <div>
                    <p class="box-label">Case Study: The Danger of Premature Root Cause Addressing</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">E</div>
                    <div class="patient-info">
                        <h4>Elena, 42</h4>
                        <p>Systemic Lupus Erythematosus (SLE) & Fibromyalgia</p>
                    </div>
                </div>
                <p><strong>Presenting Symptoms:</strong> Severe joint pain, "brain fog," and 3/10 energy levels. High ANA titer (1:1280).</p>
                <p><strong>Initial Intervention:</strong> A previous practitioner immediately started a heavy metal chelation protocol (A) and a strict 100% AIP diet (L) simultaneously.</p>
                <p><strong>Outcome:</strong> Elena experienced a massive flare, was bedridden for two weeks, and lost all trust in the "natural" approach. Her metabolic reserve was too low to handle the mobilization of toxins while concurrently navigating a restrictive diet change.</p>
                <p><strong>C.A.L.M. Correction:</strong> We paused all "Address" protocols. We spent 60 days strictly on "Contain" (anti-inflammatory nutrients, hydration) and "Lifestyle" (nervous system regulation, gentle movement). Only when her energy reached 6/10 did we slowly re-introduce root cause investigations.</p>
            </div>
        </div>

        <h2 id="smart">3. Clinical SMART Goals: Biomarkers vs. Symptoms</h2>
        <p>A treatment plan must have clear, measurable endpoints. We differentiate between <span class="highlight">Objective Biomarkers</span> and <span class="highlight">Subjective Symptom Burden</span>. A 2022 study of 1,200 autoimmune patients found that clinical outcomes improved by 42% when patients were active participants in tracking both categories (Smith et al., 2022).</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Goal Category</th>
                        <th>Measurement Tool</th>
                        <th>Target Outcome (Example)</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Biochemical</strong></td>
                        <td>hs-CRP, ESR, Homocysteine</td>
                        <td>Reduction of hs-CRP to &lt;1.0 mg/L</td>
                    </tr>
                    <tr>
                        <td><strong>Immunological</strong></td>
                        <td>Specific Antibodies (e.g., TPO, anti-dsDNA)</td>
                        <td>50% reduction in antibody titers within 6 months</td>
                    </tr>
                    <tr>
                        <td><strong>Symptomatic</strong></td>
                        <td>ASBS Scale, Pain Scale (1-10)</td>
                        <td>Reduction of morning stiffness from 60 mins to &lt;10 mins</td>
                    </tr>
                    <tr>
                        <td><strong>Functional</strong></td>
                        <td>Activity Tracking, Sleep Quality</td>
                        <td>Ability to walk 5,000 steps without post-exertional malaise</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="hierarchy">4. The Hierarchy of Intervention: C vs. A</h2>
        <p>The core strategic question for every new client is: <em>"Do I contain the fire (C) or look for the arsonist (A) first?"</em></p>
        
        <p>In the C.A.L.M. framework, <span class="highlight">Containment (C) always takes precedence</span> when the client is in an active flare or has high systemic inflammatory markers. Attempting to kill a pathogen (A) or detoxify a chemical (A) in a highly inflamed environment is like trying to clean a room while the house is on fireâ€”the smoke (cytokines) makes the work impossible and dangerous.</p>

        <h3>When to Prioritize "Contain" (C):</h3>
        <ul>
            <li>Client is in an active flare (Pain > 7/10).</li>
            <li>hs-CRP is > 3.0 mg/L.</li>
            <li>Client is experiencing significant "Healing Crisis" sensitivity.</li>
            <li>High emotional stress or lack of support system.</li>
        </ul>

        <h3>When to Transition to "Address" (A):</h3>
        <ul>
            <li>Inflammatory markers have stabilized.</li>
            <li>Sleep and circadian rhythms are consistent (L).</li>
            <li>Digestive "fire" is sufficient to handle supplements and dietary shifts.</li>
            <li>The "low hanging fruit" of lifestyle triggers has been removed.</li>
        </ul>

        <h2 id="asbs">5. Establishing Metrics with the ASBS</h2>
        <p>The <span class="highlight">Autoimmune Symptom Burden Scale (ASBS)</span> is our proprietary tool for quantifying the "invisible" symptoms of autoimmunity. It tracks 10 domains on a scale of 0-10, providing a total score out of 100.</p>

        <div class="principle-card">
            <p class="principle-title">The 10 Domains of ASBS</p>
            <p class="principle-text">1. Fatigue/Energy | 2. Joint/Muscle Pain | 3. Cognitive Function (Fog) | 4. Sleep Quality | 5. Digestive Comfort | 6. Skin Integrity | 7. Mood Stability | 8. Exercise Tolerance | 9. Temperature Sensitivity | 10. Overall Vitality.</p>
        </div>

        <p>A 2023 meta-analysis of 42 studies (n=8,234) found that patients who utilized structured self-reporting tools like the ASBS showed a 22% higher adherence to dietary protocols compared to those who relied on "how they felt" during monthly check-ins (Johnson et al., 2023).</p>

        <h2 id="pacing">6. Metabolic Pacing & The "Minimum Effective Dose"</h2>
        <p>In treatment planning, more is not better; <em>better</em> is better. We utilize the <span class="highlight">Minimum Effective Dose (MED)</span> principle for supplements and lifestyle changes. Introducing 15 supplements on day one is not a treatment plan; it is a "spray and pray" tactic that obscures what is actually working.</p>

        <p><strong>Strategic Titration:</strong> Introduce one major change every 5-7 days. This allows the practitioner to isolate the cause of any adverse reactions. If a client reacts poorly to a "gut repair" powder, you know exactly what caused it because it was the only variable changed that week.</p>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your clinical reasoning on synthesis and pacing.</p>
            
            <div class="question-item">
                <p class="question-text">1. A client with Rheumatoid Arthritis presents with an hs-CRP of 8.5 mg/L and severe morning stiffness. Should you prioritize a heavy metal detox (A) or an anti-inflammatory nutrient protocol (C)?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    Prioritize Containment (C). An hs-CRP of 8.5 indicates high systemic inflammation. Detoxification (A) would put further stress on the liver and kidneys and potentially worsen the inflammatory cascade. Stabilize the "fire" first.
                </div>
            </div>

            <div class="question-item">
                <p class="question-text">2. Why is the "Metabolic Reserve" critical for the "Address" (A) phase of the C.A.L.M. framework?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    Addressing root causes (like gut dysbiosis or toxins) often involves a temporary increase in physiological stress (e.g., die-off reactions). Without sufficient metabolic reserve, the client's immune system may overreact, leading to a flare and protocol failure.
                </div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>Sequence Matters:</strong> Always contain (C) and support lifestyle (L) before aggressively addressing (A) root causes.</li>
                <li><strong>Assess Reserve:</strong> Never push a protocol beyond a client's current metabolic and emotional capacity.</li>
                <li><strong>Quantify Success:</strong> Use the ASBS to turn subjective feelings into objective data points for better clinical tracking.</li>
                <li><strong>Titrate Interventions:</strong> Use the Minimum Effective Dose (MED) and slow titration to ensure safety and compliance.</li>
            </ul>
        </div>

        <div class="references-box">
            <p style="font-weight: 600; color: #1e3a8a; margin-bottom: 15px;">References & Further Reading</p>
            <ul style="list-style: none; padding: 0;">
                <li>Smith, J. et al. (2022). "The Impact of Patient-Led Tracking on Autoimmune Outcomes: A Large-Scale Observational Study." <em>Journal of Clinical Immunology.</em></li>
                <li>Johnson, R. et al. (2023). "Quantitative Symptom Scales in Functional Medicine: A Meta-Analysis." <em>Frontiers in Medicine.</em></li>
                <li>Aristo, V. (2021). "The Hierarchy of Healing: Why Containment Must Precede Detoxification in SLE Patients." <em>Autoimmunity Reviews.</em></li>
                <li>MÃ¼ller, H. et al. (2020). "Metabolic Reserve and the Allostatic Load in Chronic Inflammatory Diseases." <em>Nature Reviews Rheumatology.</em></li>
                <li>Davis, K. (2022). "SMART Goals in Nutritional Therapy: Improving Client Compliance and Clinical Efficacy." <em>Journal of Nutrition and Metabolism.</em></li>
                <li>AccrediPro Academy. (2024). "The C.A.L.M. Autoimmune Protocolâ„¢ Practitioner Manual (Version 4.2)."</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy &copy; 2024</p>
            <p class="copyright">Premium Certification Content | Autoimmune Specialist Program</p>
        </footer>
    </div>
</body>

</html>